We are pleased to announce that the third annual Gut Microbiome Conference will be held September 16-17, 2017 at the Hyatt Huntington Beach in California. Our conference theme for this year is, "A Decade of Microbiome Work: Where Do We Stand?" The Gut Microbiome Conference has become a successful event for keeping healthcare professionals and scientists informed on the latest advances in the human microbiome science in a one-of-a-kind platform that provides attendees the opportunity to interact with the leading authorities in gut microbiome research and education. Each meeting builds upon the momentum and success of the previous one; last year over 160 people attended the program for a rich educational exchange and clinical dialogue. This year, we are confident we will surpass last year's attendance and again will deliver a successful meeting.

It is increasingly clear that influencing the gut microbiome has
the potential to revolutionize the management of not only infectious disease states, but a broad range of other conditions in which
the microbiome plays a critical role.

The Gut Microbiome Conference was conceived in 2013 as a mechanism for bringing together local and national scientists, physicians, and other health care providers with direct research and/or treatment interest in modulating the gut microbiome to improve human health. Forums such as these play a key role in immersing both clinicians and researchers in a comprehensive educational experience designed to explore the gut microbiome and the potential to revolutionize the management of not only infectious disease states but also a broad range of other conditions in which the microbiome plays a critical role. Collectively, the gut's flora has a metabolic activity equivalent to an organ, leading some to suggest that resident bacterial flora is "the neglected organ". In fact, the human digestive tract contains nearly 100 times more single-celled organisms than the sum total of all human cells in the body. As bacteria have existed long before humans, it is safe to assume that humans have evolved in this "contaminated" environment and the evolution was in ways mutualistic and symbiotic. The intestine plays host to a broadly diversified bacterial community that is separated from the internal milieu by only a single layer of epithelial cells. Data suggests that the microbiota play an important role in the development and perpetuation of irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), obesity, celiac disease, and potentially in fatty liver disease, among many other conditions.

The conference will be co-chaired by the course directors. Global and regionally-renowned clinical experts will assist in the development of the educational content and will serve as faculty at the conference. Faculty members will provide critical information with the intent of delivering a focused educational update on the most clinically-relevant evolving data on existing treatment, diagnostic modalities, advances in new treatment options and on improving patient outcomes. Topics currently planned to be covered include the role of the microbiota in IBS, IBD, obesity, fatty liver disease, celiac disease, cancer, and neurological conditions. The format of the meeting will consist of plenary lectures, case-based parallel meetings, and panel discussions with ample time provided for direct interaction both at the formal meetings and after each presentation.


Gut Microbiome Course Directors

Ian Carroll, PhD

UNC Chapel Hill
Chapel Hill, NC

Mark Pimentel, MD, FRCP(C)

Cedars-Sinai Medical Center
Los Angeles, CA

Conference Information  Hotel Information